AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 188 filers reported holding AXSOME THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 3.71 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,005 | +273.6% | 8,301 | +122.1% | 0.00% | +200.0% |
| Q2 2023 | $269 | +17.0% | 3,737 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $230 | -20.1% | 3,737 | 0.0% | 0.00% | -50.0% |
| Q4 2022 | $288 | -99.8% | 3,737 | 0.0% | 0.00% | +100.0% |
| Q3 2022 | $167,000 | +16.8% | 3,737 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $143,000 | -7.7% | 3,737 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $155,000 | +9.9% | 3,737 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $141,000 | +14.6% | 3,737 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $123,000 | -51.2% | 3,737 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $252,000 | +18.9% | 3,737 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $212,000 | -30.3% | 3,737 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $304,000 | +14.3% | 3,737 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $266,000 | -13.4% | 3,737 | 0.0% | 0.00% | -50.0% |
| Q2 2020 | $307,000 | +39.5% | 3,737 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $220,000 | – | 3,737 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 1,132,645 | $37,332,000 | 32.86% |
| MORGAN JESS S & CO INC | 113,430 | $3,739,000 | 2.47% |
| Fairmount Funds Management LLC | 187,598 | $6,183,000 | 2.25% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 1,423,653 | $46,924,000 | 1.43% |
| WMS Partners, LLC | 250,000 | $8,240,000 | 1.21% |
| Beck Bode, LLC | 102,127 | $3,366,000 | 0.94% |
| RTW INVESTMENTS, LP | 1,616,497 | $53,280,000 | 0.80% |
| MPM BioImpact LLC | 110,155 | $3,631,000 | 0.56% |
| Endurant Capital Management LP | 52,048 | $1,716,000 | 0.39% |
| Bellevue Group AG | 752,945 | $24,817,000 | 0.25% |